Table 3 Frequencies of LI-RADS Imaging Features of HCCs between in Contrast-Enhanced CT and Gadoxetic Acid-Enhanced MRI.

From: Improved diagnosis of histological capsule in hepatocallular carcinoma by using nonenhancing capsule appearance in addition to enhancing capsule appearance in gadoxetic acid-enhanced MRI

Variable

Reader 1

Reader 2

CE-CT

EOB-MRI

p value

CE-CT

EOB-MRI

p value

Observation size (mm)

48.1 ± 34.8

47.6 ± 34.8

.082

47.4 ± 34.2

47.1 ± 35.2

.118

Nonrim APHE

94.7% (143/151)

90.7% (137/151)

.068

93.4% (141/151)

87.4% (132/151)

.012

Non peripheral washout

88.7% (134/151)

70.9% (107/151)

 < .001

87.4% (132/151)

74.8% (113/151)

 < .001

TP hypointensity

–

88.1% (133/151)

.203

–

90.1% (136/151)

.134

Enhancing capsule

71.5% (108/151)

56.3% (85/151)

 < .001

70.9% (107/151)

61.6% (93/151)

.016

Enhancing/nonenhancing capsule

–

74.2% (112/151)

.59

–

72.8% (110/151)

.465

  1. Data are expressed as mean ± standard deviation for continuous variable and frequency (count) for categorical variables.
  2. The frequencies of TP hypointensity was compared with nonperipheral “washout”, and enhancing/nonenhancing “capsule” in EOB-MRI was compared with enhancing “capsule” in CE-CT.
  3. CE-CT contrast-enhanced CT, EOB-MRI gadoxetic acid-enhanced MRI, APHE arterial phase hyperenhancement, TP transitional phase.
Back to article page